Bottom line
JANIX vs JANVX: the short answer
JANIX (Janus Henderson Triton Fund) and JANVX (Janus Henderson Venture Fund) share a meaningful slice of their top holdings — about 64% by weight.
Both charge the same expense ratio (0.79%).
Updated Nov 19, 2026
JANIX vs JANVX side by side
| JANIX | JANVX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Janus Henderson | Janus Henderson |
| Category | Large Blend | Large Blend |
| Expense ratio | 0.79% | 0.79% |
| Annual cost per $10k | $79 | $79 |
| 10-yr cost on $10k (prospectus) | $978 | $978 |
| Max front load | — | — |
| 12b-1 fee | — | — |
| 1-yr return | — | — |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +29.4% | +29.7% |
| Worst quarter | −27.8% | −25.8% |
| Net assets (fund) | $5.9B | $3.6B |
| Number of holdings | 148 | 175 |
| Portfolio turnover | 2% | 24% |
| Returns as of | — | — |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | JANIX | JANVX | Difference |
|---|---|---|---|
| 2025 | +9.7% | +9.0% | +0.7% |
| 2024 | +10.4% | +14.0% | −3.6% |
| 2023 | +14.6% | +16.1% | −1.5% |
| 2022 | −23.7% | −24.2% | +0.5% |
| 2021 | +7.1% | +7.7% | −0.6% |
| 2020 | +28.5% | +31.7% | −3.2% |
| 2019 | +28.4% | +30.8% | −2.4% |
| 2018 | −5.2% | −6.6% | +1.4% |
| 2017 | +27.0% | +24.3% | +2.7% |
| 2016 | +10.5% | +7.2% | +3.4% |
Source: Fund prospectus bar charts
Holdings overlap
17 of JANIX's top 25 holdings also appear in JANVX's top 25.
| Holding | JANIX | JANVX |
|---|---|---|
| Ligand Pharmaceuticals, Inc. | 2.63% | 2.41% |
| Glaukos Corp. | 2.49% | 2.59% |
| Aramark | 1.99% | 1.42% |
| Tower Semiconductor Ltd. | 1.93% | 1.89% |
| Revolution Medicines, Inc. | 1.78% | 1.99% |
| Lantheus Holdings, Inc. | 1.71% | 1.45% |
| Casey's General Stores, Inc. | 1.70% | 1.70% |
| Legence Corp. | 1.70% | 1.73% |
| Sensient Technologies Corp. | 1.67% | 1.57% |
| Rentokil Initial plc | 1.67% | 1.34% |
| Mirum Pharmaceuticals, Inc. | 1.56% | 1.52% |
| OSI Systems, Inc. | 1.52% | 1.59% |
| SPX Technologies, Inc. | 1.50% | 2.12% |
| MACOM Technology Solutions Holdings, Inc. | 1.49% | 1.39% |
| Globus Medical, Inc. | 1.48% | 1.32% |
Source: SEC Form N-PORT
JANIX top 10
- Flex Ltd. — 3.75%
- Teledyne Technologies, Inc. — 2.71%
- Ligand Pharmaceuticals, Inc. — 2.63%
- Glaukos Corp. — 2.49%
- Aramark — 1.99%
- Tower Semiconductor Ltd. — 1.93%
- Sterling Infrastructure, Inc. — 1.80%
- Revolution Medicines, Inc. — 1.78%
- Lantheus Holdings, Inc. — 1.71%
- Casey's General Stores, Inc. — 1.70%
JANVX top 10
- Glaukos Corp. — 2.59%
- Ligand Pharmaceuticals, Inc. — 2.41%
- Perimeter Solutions, Inc. — 2.19%
- SPX Technologies, Inc. — 2.12%
- Revolution Medicines, Inc. — 1.99%
- Tower Semiconductor Ltd. — 1.89%
- CECO Environmental Corp. — 1.87%
- Legence Corp. — 1.73%
- Casey's General Stores, Inc. — 1.70%
- Janus Henderson Cash Liquidity Fund LLC — 1.64%
FAQ
What is the difference between JANIX and JANVX?
JANIX (Janus Henderson Triton Fund) and JANVX (Janus Henderson Venture Fund) share a meaningful slice of their top holdings — about 64% by weight. Both charge the same expense ratio (0.79%).
Which is cheaper, JANIX or JANVX?
JANIX has the lower expense ratio (0.79%).
Should I own both JANIX and JANVX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.